Taro Pharm Inds (TARO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
(Values in U.S. thousands)
| 03-2023 | 03-2022 | 03-2021 | 03-2020 | 03-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 25,445 | 58,266 | -400,740 | 244,550 | 282,122 |
| Depreciation Amortization | 40,299 | 39,254 | 23,680 | 21,383 | 18,597 |
| Income taxes - deferred | 16,802 | 23,200 | -38,413 | 7,584 | 12,262 |
| Accounts receivable | 32,708 | -9,239 | 14,448 | 3,971 | -31,413 |
| Accounts payable and accrued liabilities | 1,649 | -2,129 | 32,308 | -6,202 | 9,881 |
| Other Working Capital | -37,907 | -279,027 | 460,659 | 10,649 | 37,182 |
| Other Operating Activity | -47,246 | 10,977 | -46,172 | -10,330 | -4,922 |
| Operating Cash Flow | $31,750 | $-158,698 | $45,770 | $271,605 | $323,709 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -105,709 | -66,670 | 84,885 | -269,769 | 217,135 |
| PPE Investments | -17,577 | -11,800 | -16,983 | -26,610 | -27,018 |
| Net Acquisitions | N/A | 7,407 | N/A | N/A | N/A |
| Purchase Of Investment | -1,976 | -99,275 | N/A | N/A | 70,685 |
| Purchase Sale Intangibles | -294 | -243 | -161 | -1,783 | -3,666 |
| Other Investing Activity | -294 | -243 | -161 | -1,783 | -3,666 |
| Investing Cash Flow | $-125,556 | $-170,581 | $67,741 | $-298,162 | $257,136 |
| Cash Flows From Financing Activities | |||||
| Common Stock Repurchased | N/A | -24,934 | -24,196 | -26,984 | -88,849 |
| Dividend Paid | N/A | N/A | N/A | N/A | -500,000 |
| Financing Cash Flow | $N/A | $-24,934 | $-24,196 | $-26,984 | $-588,849 |
| Exchange Rate Effect | -2,833 | 170 | 2,508 | -556 | -1,156 |
| Beginning Cash Position | 251,134 | 605,177 | 513,354 | 567,451 | 576,611 |
| End Cash Position | 154,495 | 251,134 | 605,177 | 513,354 | 567,451 |
| Net Cash Flow | $-96,639 | $-354,043 | $91,823 | $-54,097 | $-9,160 |
| Free Cash Flow | |||||
| Operating Cash Flow | 31,750 | -158,698 | 45,770 | 271,605 | 323,709 |
| Capital Expenditure | -17,577 | -11,800 | -16,991 | -26,631 | -26,992 |
| Free Cash Flow | 14,173 | -170,498 | 28,779 | 244,974 | 296,717 |